Study serum anti-Mullerian hormone levels in women undergoing IVF and its association with affecting factors

Shahla Farzipour; Faranak Jalilvand; Shayan Shabani Shojaei

doi:10.18203/2320-6012.ijrms20233011

Authors

Shahla Farzipour Department of Gynecology and Obstetrics, School of Medicine, Ardabil University of Medical Science, Ardabil, Iran
Faranak Jalilvand Department of Gynecology and Obstetrics, School of Medicine, Ardabil University of Medical Science, Ardabil, Iran
Shayan Shabani Shojaei Department of Gynecology and Obstetrics, School of Medicine, Ardabil University of Medical Science, Ardabil, Iran

DOI:

https://doi.org/10.18203/2320-6012.ijrms20233011

Keywords:

Anti-Mullerian Hormone, Infertility, Pregnancy

Abstract

Background: Infertility means inability of pregnancy after one year of natural continuous intercourse, not using any prevention which is one of the most important problems in every human society. The average rate of infertility in different societies is been estimated to be 8-12%. The aim of this study was to determine the level of anti-Mullerian hormone (AMH) in women undergoing IVF and its associations with effective factors.

Methods: This was a cross-sectional study which was done by using library and field methods. A number of 170 women with the diagnosis of infertility referring to the infertility clinic of Alavi hospital in Ardabil city from August 2021 to December 2021 were enrolled randomly in the study and their clinical data including demographic, anthropometric and hormone levels were gathered and then analyzed by using statistical methods in SPSS version 22 software.

Results: The mean age of women were 31.7±4.68 and AMH level were 3.35±2 ng/ml. There was a strong association between age and AMH level (r=0.68, p=0.001). There was not a significant correlation BMI and AMH levels. In women with the complaint of secondary infertility, prevalence of AMH deficiency was significantly lower than other women (p=0.045). There was no difference in AMH levels between regular and irregular monthly menses.

Conclusions: It can be concluded from our study that increase of age is one of the main factors in AMH levels. Also, the deficiency of this hormone can be a cause in secondary infertility.

Metrics

Metrics Loading ...

References

Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion. BJOG. 2002;109(11):1281-9.

Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th edn. Philadelphia, PA: Lippincott Williams and Wilkins; 2010.

Roupa Z, Polikandrioti M, Sotiropoulou P, Faros E, Koulouri A, Wozniak G, et al. Causes of infertility in women at reproductive age. Health Sci J. 2009;3(2):17-37.

Wallace WHB, Kelsey TW. Human ovarian reserve from conception to the menopause. J Reprod Infertil. 2010;5(1):77-87.

Burger HG, Dudley EC, Hopper JL, Shelley JM, Green ADELE, Smith ANTHONY, et al. The endocrinology of the menopausal transition. J Clin Endocrinol Metab. 1995;80(12):3537-45.

Visser JA, Jong FH, Laven JS, Themmen AP. Anti-Mullerian hormone: a new marker for ovarian function. J Reprod Infertil. 2006;131(1):1-9.

Broer SL, Eijkemans MJC, Scheffer GJ, van Rooij IAJ, de Vet A, Themmen APN, et al. Anti-Müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96(8):2532-9.

Erfanian MK, Khalilifar M, H. Investigate the relationship between serum hormone anti-Mullerian and results of assisted reproductive technology cycles in infertile patients. Iran J Med Phys. 2012;1393;4(2):1-16.

Aydın GA, Yavuz A, Terzi H, Kutlu T. Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI. Iran J Reprod Med. 2015;13(4):231-6.

Buyuk E, Seifer DB, Illions E, Grazi RV, Lieman H. Elevated body mass index is associated with lower serum anti-Mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil Steril. 2011;95(7):2364-8.

Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci. 2015;22(5):519-26.

Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC-L, Strauss JF 3rd. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2007;87(1):101-6.

Su HI, Sammel MD, Freeman EW, Lin H, DeBlasis T, Gracia CR. Body size affects measures of ovarian reserve in late reproductive age women. Menopause. 2008;15(5):857-61.

Halawaty S, ElKattan E, Azab H, ElGhamry N, Al-Inany H. Effect of obesity on parameters of ovarian reserve in premenopausal women. J Obstet Gynaecol Can. 2010;32(7):687-90.

Simões-Pereira J, Nunes J, Aguiar A, Sousa S, Rodrigues C, Sampaio Matias J, et al. Influence of body mass index in anti-Müllerian hormone levels in 951 non-polycystic ovarian syndrome women followed at a reproductive medicine unit. Endocr Pract. 2018;61(1):144-8.

La Marca A, Spada E, Grisendi V, Argento C, Papaleo E, Milani S, et al. Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. Eur J Obstet Gynecol Reprod Biol. 2012;163(2):180-4.

Albu D, Albu A. The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients. Endocr Pract. 2019;63(1):157-63.

Hehenkamp WJK, Looman CWN, Themmen APN, de Jong FH, Te Velde ER, Broekmans FJM. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91(10):4057-63.

Marsh EE, Bernardi LA, Steinberg ML, de Chavez PJ, Visser JA, Carnethon MR, et al. Novel correlates between anti-Müllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old). Fertil Steril. 2016;106(2):443-50.

Dólleman M, Verschuren WMM, Eijkemans MJC, Dollé MET, Jansen EHJM, Broekmans FJM, et al. Reproductive and lifestyle determinants of anti-müllerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98(5):2106-15.

Benksim A, Elkhoudri N, Addi RA, Baali A, Cherkaoui M. Difference between primary and secondary infertility in Morocco: Frequencies and associated factors. Int J Fertil Steril. 2018;12(2):142.